Navidea Biopharmaceuticals IncのFCF yield
Navidea Biopharmaceuticals IncのFCF yieldは何ですか。
Navidea Biopharmaceuticals IncのFCF yieldは-13.92%です。
FCF yieldの定義は何ですか。
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
NYSEMKTのセクタHealth CareにおけるFCF yieldの企業と比べるNavidea Biopharmaceuticals Inc
Navidea Biopharmaceuticals Incは何をしますか。
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Navidea Biopharmaceuticals Incと類似のfcf yield
- Ampio Pharmaceuticals IncのFCF yieldは-13.96%です。
- UPM-Kymmene OyjのFCF yieldは-13.95%です。
- iRobotのFCF yieldは-13.95%です。
- Goldstar MineralsのFCF yieldは-13.94%です。
- ScoZinc MiningのFCF yieldは-13.93%です。
- Hertz GlobalのFCF yieldは-13.93%です。
- Navidea Biopharmaceuticals IncのFCF yieldは-13.92%です。
- Integra ResourcesのFCF yieldは-13.91%です。
- Integra ResourcesのFCF yieldは-13.91%です。
- Marvel DiscoveryのFCF yieldは-13.90%です。
- Microba Life Sciences LtdのFCF yieldは-13.89%です。
- EmperorのFCF yieldは-13.89%です。
- Perma-Fix Environmental ServicesのFCF yieldは-13.88%です。